Growth Metrics

Bruker (BRKR) Other Accumulated Expenses (2016 - 2026)

Bruker filings provide 16 years of Other Accumulated Expenses readings, the most recent being $70.5 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 35.32% to $70.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.5 million, a 35.32% increase, with the full-year FY2025 number at $70.5 million, up 35.32% from a year prior.
  • Other Accumulated Expenses hit $70.5 million in Q4 2025 for Bruker, down from $604.0 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $604.0 million in Q3 2025 to a low of $52.1 million in Q4 2024.
  • Median Other Accumulated Expenses over the past 5 years was $486.8 million (2021), compared with a mean of $442.8 million.
  • The widest YoY moves for Other Accumulated Expenses: up 61.69% in 2024, down 89.1% in 2024.
  • Bruker's Other Accumulated Expenses stood at $481.2 million in 2021, then dropped by 27.89% to $347.0 million in 2022, then surged by 37.81% to $478.2 million in 2023, then crashed by 89.1% to $52.1 million in 2024, then skyrocketed by 35.32% to $70.5 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $70.5 million (Q4 2025), $604.0 million (Q3 2025), and $570.6 million (Q2 2025) per Business Quant data.